Invention Application
- Patent Title: HISTONE DEMETHYLASE INHIBITORS FOR TREATING CANCERS
-
Application No.: US17596816Application Date: 2020-06-20
-
Publication No.: US20220306584A1Publication Date: 2022-09-29
- Inventor: Jer-Tsong HSIEH , Jung-Mo AHN , Zhi-Ping LIU
- Applicant: The Board of Regents of the University of Texas System
- Applicant Address: US TX Austin
- Assignee: The Board of Regents of the University of Texas System
- Current Assignee: The Board of Regents of the University of Texas System
- Current Assignee Address: US TX Austin
- International Application: PCT/US2020/038843 WO 20200620
- Main IPC: C07D215/26
- IPC: C07D215/26 ; C07D401/12 ; C07D401/14 ; C07D405/14 ; A61P35/00

Abstract:
The present disclosure provides a new series of 8-hydroxyquinoline derivatives/analogs that are potent KDM4 inhibitors with high activity and selectivity against KDM4 enzymes. Also disclosed are the pharmaceutical compositions comprising such 8-hydroxyquinoline-based potent KDM4 inhibitors, or a pharmaceutically acceptable salt thereof, and method of use thereof, for treating cancer and neoplastic diseases and the like.
Information query